By VC News Daily
NEW YORK, NY, Formation Bio, a tech-driven and AI-native pharma company, announced that it has raised $372MM of Series D financing.
Formation Bio, a tech-driven and AI-native pharma company, announced that it has raised $372MM of Series D financing. The financing was led by a16z with significant participation from Sanofi. Current investors also joined the round, including Sequoia, Thrive, Emerson Collective, and Lachy Groom, along with new investors, such as SV Angel Growth and FPV Ventures. This round reflects a material step up from the company’s Series C valuation.
(c) by Massinvestor, Inc. For contact info, please check out our about page.